natgillin/translations-raw huggingface dataset:
The claim proposed by the applicant was, inter alia, worded as follows: ‘helps/supports/maintains concentration’.
Komisija in države članice so 21. februarja 2014 prejele znanstveno mnenje Agencije, ki je na podlagi predloženih podatkov ugotovila, da vzročno-posledična povezava med uživanjem citidin 5′-difosfoholina in navedeno trditvijo ni utemeljena.
On 24 February 2014, the Commission and the Member States received the scientific opinion from the Authority, which concluded that on the basis of the data presented, a cause and effect relationship had not been established between the consumption of Rosbacher drive® and the claimed effect.
Družba Hassia Mineralquellen GmbH & Co KG je v skladu s členom 13(5) Uredbe (ES) št. 1924/2006 predložila vlogo, Agencija pa je morala pripraviti mnenje o zdravstveni trditvi v zvezi z učinki Rosbacher drive® na izboljšanje pozornosti (vprašanje št.
The comments from the applicants and the members of the public received by the Commission pursuant to Article 16(6) of Regulation (EC) No 1924/2006 have been considered when setting the measures provided for in this Regulation.
EFSA-Q-2013-00444) [4].
The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,
Vložnik je med drugim predlagal naslednjo trditev: „Pomaga/podpira/ohranja koncentracijo“.
HAS ADOPTED THIS REGULATION:
Komisija in države članice so 24. februarja 2014 prejele znanstveno mnenje Agencije, ki je na podlagi predloženih podatkov ugotovila, da vzročno-posledična povezava med uživanjem Rosbacher drive® in navedeno trditvijo ni utemeljena.
Article 1
Pri določanju ukrepov iz te uredbe so bile upoštevane pripombe, ki so jih vložniki in predstavniki javnosti poslali Komisiji v skladu s členom 16(6) Uredbe (ES) št. 1924/2006.
The health claims listed in the Annex to this Regulation shall not be included in the Union list of permitted claims as provided for in Article 13(3) of Regulation (EC) No 1924/2006.
Ukrepi iz te uredbe so v skladu z mnenjem Stalnega odbora za rastline, živali, hrano in krmo –
Done at Brussels, 11 March 2015.
Člen 2
OJ L 404, 30.12.2006, p. 9.
V Bruslju, 11. marca 2015
Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data
Zdravstvena trditev po členu 13(5), ki je utemeljena na novih znanstvenih dokazih in/ali vključuje zahtevo za zakonsko zaščito podatkov
Padina pavonica-extract in Dictyolone®
Izvleček alge Padina pavonica v proizvodu Dictyolone®
Improves bone density through calcitrophic effects and through the physiological restoration of proteinous bone, particular in bone loss brought about by the aging process on normal healthy persons
Izboljša kostno gostoto s kalcitrofičnim delovanjem in fiziološko obnovo beljakovinske osnove kostnine, zlasti pri izgubi kostnine zaradi staranja pri sicer zdravih osebah.
Cytidine 5′-diphosphocholine (CDP-choline or citicoline)
Citidin 5′-difosfoholin (CDP-holin ali citikolin)
CDP-choline in oral solution as source of choline contributes to the maintenance of normal function of the ophthalmic nervous structures
CDP-holin v oralni raztopini kot vir holina prispeva k ohranjanju normalne funkcije očesnih živčnih struktur.
Helps/supports/maintains concentration
Pomaga/podpira/ohranja koncentracijo.
amending Annex III to Regulation (EC) No 1925/2006 of the European Parliament and of the Council as regards Ephedra species and Yohimbe (Pausinystalia yohimbe (K. Schum) Pierre ex Beille)
o spremembi Priloge III k Uredbi (ES) št. 1925/2006 Evropskega parlamenta in Sveta glede vrste Ephedra in johimbe (Pausinystalia yohimbe (K. Schum) Pierre ex Beille)
Having regard to Regulation (EC) No 1925/2006 of the European Parliament and of the Council of 20 December 2006 on the addition of vitamins and minerals and of certain other substances to foods [1], and in particular Article 8(2) thereof,
ob upoštevanju Uredbe (ES) št. 1925/2006 Evropskega Parlamenta in Sveta z dne 20. decembra 2006 o dodajanju vitaminov, mineralov in nekaterih drugih snovi živilom [1] in zlasti člena 8(2) Uredbe,
Pursuant to Article 8(2) of Regulation (EC) No 1925/2006, a Member State may request the Commission to initiate a procedure to include a substance or an ingredient containing a substance other than a vitamin or a mineral in Annex III to Regulation (EC) No 1925/2006 listing the substances whose use in foods is prohibited, restricted or under Union scrutiny, if that substance is associated with a potential risk to consumers as defined by Article 8(1) of Regulation (EC) No 1925/2006.
V skladu s členom 8(2) Uredbe (ES) št. 1925/2006 lahko država članica Komisijo pozove, naj začne postopek za vključitev snovi ali sestavine, ki vsebuje snov, ki ni vitamin ali mineral, v Prilogo III k Uredbi (ES) št. 1925/2006, ki vsebuje seznam snovi, katerih uporaba v živilih je prepovedana, omejena ali pod strogim nadzorom Unije, če je navedena snov povezana s potencialnim tveganjem za potrošnike, kot je opredeljeno v členu 8(1) Uredbe (ES) št. 1925/2006.
On 7 September 2009, Germany sent a request to the Commission regarding the possible harmful effects associated with the intake of Yohimbe (Pausinystalia yohimbe (K. Schum) Pierre ex Beille) and Ephedra species and their preparations, and asked the Commission to initiate the procedure under Article 8 of Regulation (EC) No 1925/2006 for those two substances.
Nemčija je 7. septembra 2009 Komisiji poslala zahtevo glede možnih škodljivih učinkov, povezanih z vnosom johimbe (Pausinystalia yohimbe (K. Schum) Pierre ex Beille) in vrste Ephedra ter njunih pripravkov, in Komisijo pozvala, naj za navedeni snovi začne postopek iz člena 8 Uredbe (ES) št. 1925/2006.
The request by Germany fulfilled the necessary conditions and requirements laid down in Articles 3 and 4 of Commission Implementing Regulation (EU) No 307/2012 [2].
Zahteva Nemčije je izpolnjevala potrebne pogoje in zahteve, določene v členih 3 in 4 Izvedbene uredbe Komisije (EU) št. 307/2012 [2].
On 9 September 2011, the Commission asked the European Food Safety Authority (hereafter ‘the Authority’) to evaluate the safety in use of Ephedra and Yohimbe (Pausinystalia yohimbe (K. Schum) Pierre ex Beille) species in food.
Komisija je 9. septembra 2011 zaprosila Evropsko agencijo za varnost hrane (v nadaljnjem besedilu: Agencija) za oceno varnosti pri uporabi vrst Ephedra in johimbe (Pausinystalia yohimbe (K. Schum) Pierre ex Beille) v živilih.
On 3 July 2013, the Authority adopted a scientific opinion on the evaluation of the safety in use of Yohimbe (Pausinystalia yohimbe (K. Schum) Pierre ex Beille) [3].
Agencija je 3. julija 2013 sprejela znanstveno mnenje o oceni varnosti uporabe johimbe (Pausinystalia yohimbe (K. Schum) Pierre ex Beille) [3].
It concluded that the chemical and toxicological characterisation of yohimbe bark and its preparations used in food originating from Yohimbe (Pausinystalia yohimbe (K. Schum) Pierre ex Beille) are not adequate to conclude on their safety as ingredients of food.
V njem je ugotovila, da kemijske in toksikološke lastnosti lubja johimbe in njegovih pripravkov, ki se uporabljajo v živilih, ki izvirajo iz johimbe (Pausinystalia yohimbe (K. Schum) Pierre ex Beille), ne zadostujejo za sklepne ugotovitve o njihovi varnosti kot živilski sestavini.
Therefore, it was not possible for the Authority to provide advice on a daily intake of yohimbe bark and its preparations that does not give rise to concerns for human health.
Zato Agencija ni mogla pripraviti mnenja o priporočenem dnevnem vnosu lubja johimbe in njegovih pripravkov, ki ne bi pomenil tveganja za zdravje ljudi.
On 6 November 2013, the Authority adopted a scientific opinion on the safety evaluation of Ephedra species for use in food [4].
Agencija je 6. novembra 2013 sprejela znanstveno mnenje o oceni varnosti vrste Ephedra za uporabo v živilih [4].
It found that although the marketing of foods containing Ephedra herb and its preparations in retail outlets is not documented in Europe, food supplements containing Ephedra herbs or their preparations that are typically used for weight loss and athletic performance can easily be purchased via the internet.
Ugotovila je, da trženje živil, ki vsebujejo zelišče Ephedra in njegove pripravke, na maloprodajnih mestih v Evropi sicer ni evidentirano, vendar pa je prek interneta enostavno kupiti prehranska dopolnila, ki vsebujejo zelišča Ephedra ali njihove pripravke, ki se običajno uporabljajo za zmanjšanje telesne teže in izvajanje športne aktivnosti.
The Authority concluded that it cannot be excluded that consumers may purchase herbal tea from Ephedra herb via the internet.
Agencija je ugotovila, da ni mogoče izključiti, da lahko potrošniki kupijo zeliščni čaj iz zelišča Ephedra prek interneta.
Given that Ephedra herb and its preparations are marketed almost exclusively as food supplements, the Authority calculated potential exposure levels to the herb from food supplements.
Glede na to, da se zelišče Ephedra in njegovi pripravki tržijo skoraj izključno kot prehranska dopolnila, je Agencija ocenila možne ravni izpostavljenosti zelišču s prehranskimi dopolnili.
It concluded that Ephedra herb and its preparations in food supplements may result in exposure to total ephedra alkaloids or ephedrine which falls within or may exceed the therapeutic dose ranges for the individual ephedra alkaloids or ephedrine, in medicinal products.
Ugotovila je, da je izpostavljenost zelišču Ephedra in njegovim pripravkom v prehranskih dopolnilih lahko enaka skupni izpostavljenosti efedrinim alkaloidom ali efedrinu, ki je v mejah terapevtskega odmerka za posamezne efedrine alkaloide ali efedrin v zdravilih ali pa jih presega.
The Authority concluded that due to the absence of adequate toxicity data, it could not provide advice on a daily intake of Ephedra herb and its preparations from all foods that does not give rise to concerns for human health.
Agencija je sklenila, da zaradi pomanjkanja ustreznih podatkov o toksičnosti ne more podati mnenja o dnevnem vnosu zelišča Ephedra in njegovih pripravkih iz vseh živil, ki ne bi pomenil tveganja za zdravje ljudi.
Nevertheless, it concluded that exposure to total ephedra alkaloids or ephedrine in foods, mainly in food supplements could lead to severe adverse effects on the cardiovascular and central nervous systems (such as hypertension and stroke), which may be enhanced in combination with caffeine.
Kljub temu je ugotovila, da skupna izpostavljenost efedrinim alkaloidom ali efedrinu v živilih, zlasti v prehranskih dopolnilih, lahko povzroči resne škodljive učinke na kardiovaskularni in centralni živčni sistem (kot sta hipertenzija in kap), ki se lahko povečajo v kombinaciji s kofeinom.
Therefore, the use of Ephedra herb and its preparations containing ephedra alkaloids in food is of significant safety concern for human health.
Zato predstavlja uporaba zelišča Ephedra in njegovih pripravkov, ki vsebujejo efedrine alkaloide, v živilih resno tveganje za zdravje ljudi.
The Commission received no comments from interested parties following publication by the Authority of its opinions on Ephedra species and on Yohimbe (Pausinystalia yohimbe (K. Schum) Pierre ex Beille).
Komisija po objavi mnenj Agencije o vrsti Ephedra in johimbe (Pausinystalia yohimbe (K. Schum) Pierre ex Beille) ni prejela pripomb zainteresiranih strani.
As there is a possibility of harmful effects on health associated with the use of Yohimbe (Pausinystalia yohimbe (K. Schum) Pierre ex Beille) and its preparations in foods, but scientific uncertainty persists, the substance should be placed under Union scrutiny and therefore, should be included in Part C of Annex III to Regulation (EC) No 1925/2006.
Ker obstaja možnost škodljivega učinka na zdravje, ki je povezan z uporabo johimbe (Pausinystalia yohimbe (K. Schum) Pierre ex Beille) in njenih pripravkov v živilih, vendar še vedno obstaja znanstvena negotovost, bi snov morala biti pod strogim nadzorom Unije in bi jo zato bilo treba vključiti v del C Priloge III k Uredbi (ES) št. 1925/2006.
Consequently, during the period of Union scrutiny and pending a decision on whether to allow the use of the substance or to place it in Part A or B of Annex III to Regulation (EC) No 1925/2006 at the end of the scrutiny period, national provisions regulating the use of Yohimbe (Pausinystalia yohimbe (K. Schum) Pierre ex Beille) in food should still apply.
Zato bi bilo treba v času strogega nadzora Unije in do odločitve o tem, ali naj se uporaba snovi po koncu obdobja strogega nadzora dovoli ali pa se snov uvrsti v del A ali del B Priloge III k Uredbi (ES) št. 1925/2006, še naprej uporabljati nacionalne določbe, ki urejajo uporabo johimbe (Pausinystalia yohimbe (K. Schum) Pierre ex Beille) v živilih.
Considering the significant safety concern associated with the use of Ephedra herb and its preparations in foods, in particular with regard to exposure to ephedra alkaloids present in food supplements, and considering that no daily intake of Ephedra herb and its preparations that does not give rise to concerns for human health could be set, the use of that substance in foods should be prohibited.
Ob upoštevanju resnega tveganja za varnost, povezanega z uporabo zelišča Ephedra in njegovih pripravkov v živilih, zlasti v zvezi z izpostavljenostjo efedrinim alkaloidom v prehranskih dopolnilih, in ob upoštevanju, da ni mogoče določiti dnevnega vnosa zelišča Ephedra in njegovih pripravkov, ki ne bi pomenil tveganja za zdravje ljudi, bi bilo treba uporabo navedene snovi v živilih prepovedati.
Article 1
Priloga III k Uredbi (ES) št. 1925/2006 se spremeni:
Annex III to Regulation (EC) No 1925/2006 is amended as follows:
v delu A se doda naslednji vnos:
in Part A, the following entry is added:
„Zelišče Ephedra in njegovi pripravki iz vrste Ephedra“
‘Ephedra herb and its preparations originating from Ephedra species’
v delu C se doda naslednji vnos:
in Part C, the following entry is added:
„Lubje johimbe in njegovi pripravki iz johimbe (Pausinystalia yohimbe (K. Schum) Pierre ex Beille)“
‘Yohimbe bark and its preparations originating from Yohimbe (Pausinystalia yohimbe (K. Schum) Pierre ex Beille)’
Člen 2
This Regulation shall be binding in its entirety and directly applicable in all Member States.
V Bruslju, 11. marca 2015
Done at Brussels, 11 March 2015.
Za Komisijo
The President
UL L 404, 30.12.2006, str. 26.
OJ L 404, 30.12.2006, p. 26.
Izvedbena uredba Komisije (EU) št. 307/2012 z dne 11. aprila 2012 o izvedbenih pravilih za uporabo člena 8 Uredbe (ES) št. 1925/2006 Evropskega Parlamenta in Sveta o dodajanju vitaminov, mineralov in nekaterih drugih snovi živilom (UL L 102, 12.4.2012, str. 2).
Commission Implementing Regulation (EU) No 307/2012 of 11 April 2012 establishing implementing rules for the application of Article 8 of Regulation (EC) No 1925/2006 of the European Parliament and of the Council on the addition of vitamins and minerals and of certain other substances to foods (OJ L 102, 12.4.2012, p. 2).
Svet EFSA za aditive za živila in hranilne vire, dodane živilom (ANS); Znanstveno mnenje o oceni varnosti vrste Ephedra za uporabo v živilih.
EFSA Journal 2013;11(7):3302.
Pierre ex Beille).
‘Yohimbe bark and its preparations originating from Yohimbe (Pausinystalia yohimbe (K. Schum) Pierre ex Beille)’ .
Zato bi bilo treba zelišče Ephedra in njegove pripravke vključiti v del A Priloge III k Uredbi (ES) št. 1925/2006.
Commission Implementing Regulation (EU) 2015/404
Izvedbena uredba Komisije (EU) 2015/404
amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances beflubutamid, captan, dimethoate, dimethomorph, ethoprophos, fipronil, folpet, formetanate, glufosinate, methiocarb, metribuzin, phosmet, pirimiphos-methyl and propamocarb
o spremembi Izvedbene uredbe (EU) št. 540/2011 glede podaljšanja obdobja odobritve aktivnih snovi beflubutamid, kaptan, dimetoat, dimetomorf, etoprofos, fipronil, folpet, formetanat, glufosinat, metiokarb, metribuzin, fosmet, pirimifos-metil in propamokarb
Having regard to Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC [1], and in particular the first paragraph of Article 17 thereof,
ob upoštevanju Uredbe (ES) št. 1107/2009 Evropskega parlamenta in Sveta z dne 21. oktobra 2009 o dajanju fitofarmacevtskih sredstev v promet in razveljavitvi direktiv Sveta 79/117/EGS in 91/414/EGS [1] ter zlasti prvega odstavka člena 17 Uredbe,
Applications have been submitted for the renewal of the approval of those active substances.
Verjetno je, da bodo odobritve navedenih aktivnih snovi prenehale veljati pred sprejetjem sklepa o njihovem podaljšanju.
Implementing Regulation (EU) No 540/2011 should therefore be amended accordingly.
Glede na cilj prvega odstavka člena 17 Uredbe (ES) št. 1107/2009 v zvezi s primeri, v katerih Komisija sprejme uredbo, ki določa, da se odobritev aktivne snovi iz Priloge k tej uredbi ne podaljša, ker merila za odobritev niso izpolnjena, Komisija določi isti datum veljavnosti kot pred to uredbo ali na datum začetka veljavnosti Uredbe, če odobritev aktivne snovi ni podaljšana, odvisno od tega, kateri datum je poznejši.
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.
V Bruslju, 11. marca 2015
Done at Brussels, 11 March 2015.
Predsednik
ANNEX
v šestem stolpcu vrstice 145 za kaptan se datum veljavnosti registracije „30. september 2017“ nadomesti z „31. julij 2018“;
Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:
v šestem stolpcu vrstice 146 za folpet se datum veljavnosti registracije „30. september 2017“ nadomesti z „31. julij 2018“;
in the sixth column, expiration of approval, of row 145, captan, the date of ‘30 September 2017’ is replaced by ‘31 July 2018’;
v šestem stolpcu vrstice 147 za formetanat se datum veljavnosti registracije „30. september 2017“ nadomesti z „31. julij 2018“;
in the sixth column, expiration of approval, of row 146, folpet, the date of ‘30 September 2017’ is replaced by ‘31 July 2018’;
v šestem stolpcu vrstice 148 za metiokarb se datum veljavnosti registracije „30. september 2017“ nadomesti z „31. julij 2018“;
in the sixth column, expiration of approval, of row 147, formetanate, the date of ‘30 September 2017’ is replaced by ‘31 July 2018’;
v šestem stolpcu vrstice 150 za dimetomorf se datum veljavnosti registracije „30. september 2017“ nadomesti z „31. julij 2018“;
in the sixth column, expiration of approval, of row 149, dimethoate, the date of ‘30 September 2017’ is replaced by ‘31 July 2018’;
v šestem stolpcu vrstice 152 za metribuzin se datum veljavnosti registracije „30. september 2017“ nadomesti z „31. julij 2018“;
in the sixth column, expiration of approval, of row 150, dimethomorph, the date of ‘30 September 2017’ is replaced by ‘31 July 2018’;
v šestem stolpcu vrstice 153 za fosmet se datum veljavnosti registracije „30. september 2017“ nadomesti z „31. julij 2018“;
in the sixth column, expiration of approval, of row 151, glufosinate, the date of ‘30 September 2017’ is replaced by ‘31 July 2018’;
v šestem stolpcu vrstice 154 za propamokarb se datum veljavnosti registracije „30. september 2017“ nadomesti z „31. julij 2018“;
in the sixth column, expiration of approval, of row 152, metribuzin, the date of ‘30 September 2017’ is replaced by ‘31 July 2018’;
v šestem stolpcu vrstice 155 za etoprofos se datum veljavnosti registracije „30. september 2017“ nadomesti z „31. julij 2018“;
in the sixth column, expiration of approval, of row 153, phosmet, the date of ‘30 September 2017’ is replaced by ‘31 July 2018’;
v šestem stolpcu vrstice 156 za pirimifos-metil se datum veljavnosti registracije „30. september 2017“ nadomesti z „31. julij 2018“;
in the sixth column, expiration of approval, of row 154, propamocarb, the date of ‘30 September 2017’ is replaced by ‘31 July 2018’;
v šestem stolpcu vrstice 157 za fipronil se datum veljavnosti registracije „30. september 2017“ nadomesti z „31. julij 2018“;
in the sixth column, expiration of approval, of row 155, ethoprophos, the date of ‘30 September 2017’ is replaced by ‘31 July 2018’;
v šestem stolpcu vrstice 158 za beflubutamid se datum veljavnosti registracije „30. november 2017“ nadomesti z „31. julij 2018“.
in the sixth column, expiration of approval, of row 156, pirimiphos-methyl, the date of ‘30 September 2017’ is replaced by ‘31 July 2018’;
Odobritve aktivnih snovi kaptan, dimetoat, dimetomorf, etoprofos, fipronil, folpet, formetanat, glufosinat, metiokarb, metribuzin, fosmet, pirimifos-metil in propamokarb prenehajo veljati 30. septembra 2017, odobritev aktivne snovi beflubutamid pa preneha veljati 30. novembra 2017.
in the sixth column, expiration of approval, of row 157, fipronil, the date of ‘30 September 2017’ is replaced by ‘31 July 2018’;
Vložene so bile vloge za podaljšanje odobritev navedenih aktivnih snovi.
in the sixth column, expiration of approval, of row 158, beflubutamid, the date of ‘30 November 2017’ is replaced by ‘31 July 2018’.
v šestem stolpcu vrstice 149 za dimetoat se datum veljavnosti registracije „30. september 2017“ nadomesti z „31. julij 2018“;
Commission Implementing Regulation (EU) 2015/405
Izvedbena uredba Komisije (EU) 2015/405
approving alpha-cypermethrin as an active substance for use in biocidal products for product-type 18
o odobritvi alfa-cipermetrina kot aktivne snovi za uporabo v biocidnih proizvodih 18. vrste proizvodov
Having regard to Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products [1], and in particular the third subparagraph of Article 89(1) thereof,
ob upoštevanju Uredbe (EU) št. 528/2012 Evropskega parlamenta in Sveta z dne 22. maja 2012 o dostopnosti na trgu in uporabi biocidnih proizvodov [1] ter zlasti tretjega pododstavka člena 89(1) Uredbe,
Commission Delegated Regulation (EU) No 1062/2014 [2] establishes a list of active substances to be evaluated with a view to their possible approval for use in biocidal products or inclusion into Annex I to Regulation (EU) No 528/2012.
Delegirana uredba Komisije (EU) št. 1062/2014 [2] določa seznam aktivnih snovi, ki jih je treba oceniti zaradi njihove morebitne odobritve za uporabo v biocidnih proizvodih ali vključitve v Prilogo I k Uredbi (EU) št. 528/2012.
That list includes alpha-cypermethrin.
Navedeni seznam vključuje alfa-cipermetrin.
Alpha-cypermethrin has been evaluated in accordance with Article 90(2) of Regulation (EU) No 528/2012 for use in biocidal products for product-type 18, insecticides, acaricides and products to control other arthropods, as defined in Annex V to Regulation (EU) No 528/2012.
Alfa-cipermetrin je bil v skladu s členom 90(2) Uredbe (EU) št. 528/2012 ocenjen za uporabo v biocidnih proizvodih 18. vrste proizvodov, insekticidi, akaricidi in proizvodi za nadzor drugih členonožcev, kot je opredeljena v Prilogi V k Uredbi (EU) št. 528/2012.
Belgium was designated as evaluating competent authority and submitted an assessment report, together with its recommendations, to the Commission on 17 November 2011 in accordance with paragraphs 4 and 6 of Article 14 of Commission Regulation (EC) No 1451/2007 [3].
Belgija, ki je bila imenovana za pristojni ocenjevalni organ, je 17. novembra 2011 v skladu s členom 14(4) in (6) Uredbe Komisije (ES) št. 1451/2007 [3] Komisiji predložila poročilo o oceni in svoja priporočila.
The opinion of the European Chemicals Agency was formulated on 17 June 2014 by the Biocidal Product Committee, having regard to the conclusions of the evaluating competent authority.
Odbor za biocidne pripravke je ob upoštevanju sklepov pristojnega ocenjevalnega organa 17. junija 2014 oblikoval mnenje Evropske agencije za kemikalije.